Prot #PTG-300-11: A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera

Project: Research project

Project Details

StatusActive
Effective start/end date11/20/23 → 11/20/26

Funding

  • Medpace Clinical Research LLC (Prot # PTG-300-11 // Prot # PTG-300-11)
  • Protagonist Therapeutics, Inc. (Prot # PTG-300-11 // Prot # PTG-300-11)